Boosting Bioavailability- How Companies are Using Advanced Technologies to Formulate Complex Molecules
Oral dosage delivery remains a cornerstone of drug development despite the proliferation of alternative dosage forms. The continued relevance of oral dosage delivery is underpinned by evolving technologies that help overcome bioavailability challenges and enable the formulation of more complex molecules.
To better understand the landscape, Catalent and FiercePharma asked 200+ people involved in the oral dose market for their views on barriers to the development of oral formulations. Improvements in formulation technology is known but costs and inhouse technical expertise are barriers to adoption.